Back to results
US 7,405,058 B2Granted
Human TSLP polynucleotides
AssigneeImmunex Corporation
InventorsJohn E. Sims, Stewart D. Lyman, Hilary Jean McKenna, Allison P. Armstrong
Life of this patent
Estimating the term…
Abstract
The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Claims13
An isolated nucleic acid molecule selected from the group consisting of:
- (a) the DNA sequence of SEQ ID NO:
- 1;
- and
- (b) an isolated nucleic acid molecule encoding a polypeptide having the amino acid sequence comprising at least 30 contiguous amino acids of the sequence of SEQ ID NO:2.
1 more element
Dependencies are inferred from the claim text.